Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Eric K. Rowinsky
Age : 63
Public asset : 6,868,493 USD
Linked companies : Biogen Inc. - Verastem, Inc. - Fortress Biotech, Inc. - Purple Biotech Ltd.
Summary 
Founder of Primrose Therapeutics, Inc., Eric K. Rowinsky currently holds the position of Chairman at Purple Biotech Ltd. and Chief Scientific Officer at Clearpath Development Co. Dr. Rowinsky is also Adjunct Professor at New York University School of Medicine and on the board of 8 other companies.

In the past Dr. Rowinsky held the position of Chairman for Navidea Biopharmaceuticals, Inc., Chief Executive Officer of Primrose Therapeutics, Inc., Chief Medical Officer for Champions Oncology, Inc., Chief Medical Officer & Executive Vice President at ImClone LLC, CMO, EVP & Head-Research & Development at Stemline Therapeutics, Inc., Director-Drug Development Institute at Cancer Therapy & Research Center Endowment, Director at Biogen Idec New Ventures, Inc., Advisor at Maxwell Asset Management LLC (US), Principal at National Cancer Institute, Clinical Professor-Medicine at Texas University of Health Center at San Antonio, Associate Professor-Oncology at The Johns Hopkins University School of Medicine and Professor at the University of Texas Health Science Center At San Antonio.

Dr. Rowinsky received an undergraduate degree from New York University and a doctorate from Vanderbilt University School of Medicine.


Current positions of Eric K. Rowinsky 
NameTitle Since
Biogen Inc.
(Pharmaceuticals)
Independent Director 2011
Verastem, Inc.
(Biotechnology & Medical Research)
Independent Director 2017
Fortress Biotech, Inc.
(Pharmaceuticals)
Vice Chairman 2010
Purple Biotech Ltd.
(Pharmaceuticals)
Chairman 2019
Clearpath Development Co. Chief Scientific Officer 2016
Biogen GmbH Member-Supervisory Board 2010
Cage Pharma, Inc. Director -
Inspirna, Inc. Director -
BioXcel Corp. Director 2017
Tusk Therapeutics Ltd. Director -
New York University School of Medicine Adjunct Professor -


Holdings of Eric K. Rowinsky 
NameEquities%Valuation
Biogen Inc. (BIIB)
(Pharmaceuticals)
16,9540.012%4,521,293 USD
Fortress Biotech, Inc. (FBIO)
(Pharmaceuticals)
720,0000.71%2,347,200 USD
Verastem, Inc. (VSTM)
(Biotechnology & Medical Research)
00.0000%0 USD


Eric K. Rowinsky: Personal Network 
Most Read News 
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
RE
11/30JACK DORSEY : Jack Dorsey chases crypto, fintech dream post Twitter
RE
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
RE
12/01JACK DORSEY : Dorsey-led Square rebrands to Block in nod to blockchain
RE
12/03CATHIE WOOD : Cathie Wood's ARK Innovation fund hits 13-month low in tech selloff
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
12/02ELON MUSK : Musk exercises more options, sells Tesla shares worth $1.01 billion
RE
11/23ERIK NORDSTROM : Nordstrom warns of supply shortages as holiday season approaches, shares plunge
RE
11/22MUKESH AMBANI : India's salesmen face ruin as tycoon Ambani targets mom-and-pop stores
RE
12/03DAVID HARRISON : U.S. Nonfarm Payrolls Up 210K in November, Unemployment Rate 4.2% -- Update
DJ
More news


© 2021 People and Ownership :   
Eric K. Rowinsky : Connections